日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenacapavir as pre-exposure prophylaxis for HIV prevention

利那卡帕韦作为HIV暴露前预防药物

Ebrahim, Sumayyah; Gloeck, Natasha; Adam, Zahiera; Tatz, Gayle; Nel, Jeremy; Sinxadi, Phumla Z; Dawood, Halima; Kredo, Tamara; Cohen, Karen

Advancing pharmacometrics in Africa-Transition from capacity development toward job creation

推进非洲的药物计量学发展——从能力建设转向创造就业机会

Pillai, Goonaseelan Colin; Mouksassi, Samer; Asiimwe, Innocent G; Rayner, Craig R; Kern, Steven; Sinxadi, Phumla; Denti, Paolo; Decloedt, Eric; Waitt, Catriona; Ogutu, Bernhards R; de Greef, Rik

NOS3 rs3918188C>A is associated with susceptibility to resistant hypertension while CES1 genetic variation was not associated with resistant hypertension among South Africans.

NOS3 rs3918188C>A 与南非人患难治性高血压的易感性相关,而 CES1 基因变异与南非人的难治性高血压无关

Katsukunya Jonathan N, Naicker Revina, Soko Nyarai D, Blom Dirk, Sinxadi Phumla, Chimusa Emile R, Rayner Brian, Jones Erika, Dandara Collet

Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid

依非韦伦和异烟肼联合用药的药代动力学、药代遗传学和毒性

Taylor, Jessica; Maartens, Gary; Sokhela, Simiso; Chandiwana, Nomathemba; Akpomiemie, Godspower; Venter, Francois; Sinxadi, Phumla

Genetic polymorphisms and adverse reactions to antituberculosis therapy

遗传多态性与抗结核治疗的不良反应

Gunter, Hannah M; Choshi, Phuti; Chimbetete, Tafadzwa; Pedretti, Sarah; Lehloenya, Rannakoe J; Sinxadi, Phumla Z; Ritchie, Marylyn D; Phillips, Elizabeth J; Haas, David W; Peter, Jonny G

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens

ADVANCE试验192周疗效和安全性最终结果,比较3种一线抗逆转录病毒疗法

Sokhela, Simiso; Venter, Willem D F; Bosch, Bronwyn; Woods, Joana; McCann, Kaitlyn; Akpomiemie, Godspower; Chandiwana, Nomathemba; Mashabane, Nkuli; Tembo, Angela; Simmons, Bryony; Lalla-Edward, Samanta; Siedner, Mark J; Sinxadi, Phumla; Hermans, Lucas; Fairlie, Lee; Vos, Alinda; Abrams, Elaine; Manne-Goehler, Jennifer M; Moorhouse, Michelle; Clayden, Polly; Norris, Shane; Qavi, Ambar; Chersich, Matthew; Masenya, Masebole; Arulappan, Natasha; Hill, Andrew

Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans

ABCB1、ADRB1、CYP3A4、CYP3A5、NEDD4L 和 NR3C2 基因的遗传变异导致南非人对难治性高血压的易感性存在差异

Katsukunya, Jonathan N; Jones, Erika; Soko, Nyarai D; Blom, Dirk; Sinxadi, Phumla; Rayner, Brian; Dandara, Collet

Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update

结核病合并HIV感染患者药物性肝损伤的管理:2024年更新

Boyles, Tom; Berhanu, Rebecca H; Gogela, Neliswa; Gunter, Hannah; Lovelock, Tamsin; Mphothulo, Ndiviwe; Parker, Arifa; Rabie, Helena; Richards, Lauren; Sinxadi, Phumla; Wattrus, Camilla; Moosa, Mahomed-Yunus

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa

南非开始使用多替拉韦抗逆转录病毒疗法后血清肌酐早期变化的决定因素

Mpofu, Rephaim; Kawuma, Aida N; Wasmann, Roeland E; Akpomiemie, Godspower; Chandiwana, Nomathemba; Sokhela, Simiso Mandisa; Moorhouse, Michelle; Venter, Willem Daniel Francois; Denti, Paolo; Wiesner, Lubbe; Post, Frank A; Haas, David W; Maartens, Gary; Sinxadi, Phumla

Validation of a quantitative multiplex LC-MS/MS assay of carvedilol, enalaprilat, and perindoprilat in dried blood spots from heart failure patients and its cross validation with a plasma assay.

对心力衰竭患者干血斑中卡维地洛、依那普利拉和培哚普利拉的定量多重 LC-MS/MS 检测方法进行验证,并与血浆检测方法进行交叉验证

Joubert Andre, Joubert Anton, van der Merwe Marthinus, Norman Jennifer, Castel Sandra, Denti Paolo, Sliwa Karen, Maartens Gary, Sinxadi Phumla, Wiesner Lubbe